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Abstract
Cerebral small vessel disease (SVD) is the major cause of vascular cognitive impairment,
resulting in significant disability and reduced quality of life. Cognitive tests have been shown
to be insensitive to change in longitudinal studies and, therefore, sensitive surrogate mark-
ers are needed to monitor disease progression and assess treatment effects in clinical trials.
Diffusion tensor imaging (DTI) is thought to offer great potential in this regard. Sensitivity of
the various parameters that can be derived from DTI is however unknown. We aimed to
evaluate the differential sensitivity of DTI markers to detect SVD progression, and to esti-
mate sample sizes required to assess therapeutic interventions aimed at halting decline
based on DTI data. We investigated 99 patients with symptomatic SVD, defined as clinical
lacunar syndrome with MRI confirmation of a corresponding infarct as well as confluent
white matter hyperintensities over a 3 year follow-up period. We evaluated change in DTI
histogram parameters using linear mixed effect models and calculated sample size esti-
mates. Over a three-year follow-up period we observed a decline in fractional anisotropy
and increase in diffusivity in white matter tissue and most parameters changed significantly.
Mean diffusivity peak height was the most sensitive marker for SVD progression as it had
the smallest sample size estimate. This suggests disease progression can be monitored
sensitively using DTI histogram analysis and confirms DTI’s potential as surrogate marker
for SVD.
Introduction
Cerebral small vessel disease (SVD) causes about 20% of ischaemic stroke, and is the major
cause of vascular cognitive impairment, including dementia. Whilst magnetic resonance imag-
ing (MRI) techniques play a crucial role in diagnosis they are also being used increasingly to
monitor disease progression and have been proposed as surrogate markers to assess the effects
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of therapeutic interventions. This latter use is of potential importance in detecting change
given that cognitive testing has been shown to be relatively insensitive in measuring longitudi-
nal decline [1,2].
Conventional MRI hallmarks of SVD include T2-white matter hyperintensities (WMH)
and lacunes of presumed vascular origin. However, diffusion tensor imaging (DTI) has been
shown to be a more sensitive measure of white matter (WM) damage in SVD detecting abnor-
malities not only within WMH but also in apparently normal appearing white matter
(NAWM) [3,4]. In cross-sectional studies correlations between DTI parameters and levels of
disability and/or cognition have been found in a number of SVD cohorts [4–9], and these cor-
relations are stronger than those with T2WMH volume [6,10]. To date, however, there is little
longitudinal DTI data to determine the sensitivity of different DTI parameters to change over
time. Determining the magnitude and variability of change over time is needed to determine
the feasibility of using DTI as a biomarker, as well as to allow estimation of sample sizes needed
to identify therapeutic efficacy in clinical trials.
Several quantitative measurements can be derived from DTI [11,12]. Mean diffusivity (MD)
describes the overall extent of water diffusion, is orientation independent and is a marker of
WM ultrastructure. Fractional anisotropy (FA) provides information on the directionality of
the diffusion tensor and therefore the organisation of and damage to the ultrastructure deter-
mined by axonal fibre packing, degree of myelination and axon diameter [13]. Axial diffusivity
(AD) is measured along the principal axis of the diffusion tensor and is considered a putative
axonal damage marker; whereas radial diffusivity (RD) is measured perpendicular to the prin-
cipal axis and thought to be sensitive to the degree of hindrance that diffusing water molecules
experience due to the axonal membrane and myelin [14,15]. Analysing the various anisotropy
and diffusivity measurements provides a range of information on the underlying WM tissue,
but with varying reliabilities and sensitivities.
This prospective longitudinal study aimed to determine the sensitivity of different DTI
parameters to WM damage over a period of 3 years in a clinically defined cohort of symptom-
atic SVD patients with MRI confirmation of a corresponding small subcortical infarct as well
as confluent WMH. It also used the DTI data to evaluate sample sizes required for clinical trials
to demonstrate treatment efficacy, and determine which DTI parameters provide the most sta-
tistical power to detect change in such studies.
Methods
2.1 Patients
Patients presenting with symptomatic SVD were recruited as part of the St George’s Cognition
and Neuroimaging in Stroke (SCANS) study [6] from stroke services in three local South London
hospitals (St George’s Hospital, King’s College Hospital and St Thomas’Hospital). Symptomatic
SVD was defined as a clinical lacunar stroke syndrome [16] with a neuroanatomically corre-
sponding small subcortical infract as well as confluent areas of WMH of presumed vascular ori-
gin on MRI graded2 on the semi-quantitative Fazekas scale [17]. Exclusion criteria were:
cardio-embolic sources of stroke, large vessel disease with>50% stenosis in intra- or extra-cra-
nial arteries, other central nervous system disorders, major psychiatric disorders and any cause of
white matter disease other than SVD. Patients were recruited at least 3 months after their last
stroke to avoid the influence of any acute ischaemic effects on neuropsychological function (the
latter analysed in a separate study). Ethical approval for the study was obtained from theWands-
worth Research Ethics Committee and all patients gave written informed consent.
One hundred and twenty one patients were recruited into the SCANS study [6,18,19] and of
these, 99 completed one or more follow-up scanning sessions; reasons for exit of the other
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patients were death (7), declining further MR scanning (6), formally withdrawing from the
total study (6), and being lost to follow-up (3) (see Fig 1 and missing data section for follow-up
scanning frequencies). For this study DTI analyses were performed on the 99 patients with fol-
low-up MRI scans available.
2.2 MRI acquisition protocol
MRI scans were performed using a 1.5-Tesla GE Signa HDxt system (General Electric, Milwau-
kee, WI, USA) with a maximum gradient amplitude of 33 mTm-1 and a proprietary head coil.
Patients were neutrally positioned in the head coil using an alignment marker at the nasal
bridge to standardise head position. Foam pads and a Velcro strap across the forehead were
used to minimise head movement during the scan.
The imaging protocol lasted approximately 45 minutes and included the following scan
sequences which all provided whole head coverage: I. axial Fluid Attenuated Inversion Recov-
ery (FLAIR): repetition time (TR) = 9000ms, echo time (TE) = 130ms, inversion time (TI) =
2200ms, 28 slices of 5mm thickness without slice gap, field of view (FOV) = 240x240mm2,
matrix = 256x192; II. coronal T1-weighted spoiled gradient recalled echo (SPGR): TR =
11.5ms, TE = 5ms, 176 slices without slice gap, FOV = 240x240mm2, matrix = 256x192, flip
angle = 18°, providing 1.1mm3 isotropic voxels; and III. axial single shot spin echo planar
Fig 1. SCANS longitudinal imaging cohort. All available DTI scans without EPI warping were used in our
analyses. Exit event coding: Death = patient passed away; Dementia = patient developed a primary dementia
syndrome; Heart implant = patient was unable to do further MR sessions due to a heart implant; ICH = subject
met exclusion criteria after intracerebral haemorrhage; Cognition only = patient withdrew fromMR sessions
but remained in study for cognition; Withdrawal = patient formally withdrew from the study; Loss to follow-
up = patient was lost to follow-up; Major stroke = patient met exclusion criteria after major ischaemic stroke;
Cardiac arrest = major cognitive impairment related to hypoxia was seen in a patient after a cardiac arrest.
doi:10.1371/journal.pone.0147836.g001
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diffusion-weighted imaging: TR = 15600ms, TE = 93.4ms, 55 slices without slice gap with iso-
tropic voxels of 2.5mm3, FOV = 240x240 mm2, matrix = 96x96, 8 non-diffusion-weighted
images (b = 0 smm-2) followed by diffusion-weighted volumes with diffusion gradients applied
(b = 1000 smm-2) in 25 non-collinear directions and the negative of these.
2.3 MRI analysis
2.3.1 Structural pre-processing and tissue segmentation. The steps used are detailed in
Lambert et al [20], but are summarised below. Initially the T1-weighted and FLAIR images
were rigidly aligned to MNI template space. Using SPM12 New Segment [21] the FLAIR and
T1-weighted images were segmented into 1mm3 isotropic voxels, providing tissue class proba-
bility maps (TPMs) for WM, grey matter (GM), and cerebrospinal fluid (CSF). These segmen-
tations were used to calculate deformation fields using a diffeomorphic registration algorithm
(Shoot toolbox SPM12 [22]). Following skull stripping of the T1-weighted and FLAIR images,
performed using the combined tissue segmentations at a threshold of 0.1, the T1-weighted and
FLAIR images were warped to the group-average-template computed from this study cohort.
A modified multivariate mixture of Gaussians SVD population specific TPMs [23] were gener-
ated to improve segmentation accuracy from the T1-weighted images for GM, WM and CSF.
Additional TPMs for WMH were generated using the FLAIR and T1-weighted images
together. SPM New Segment was subsequently re-run on the native space images using the pop-
ulation specific TPMs creating segmentation maps of GM, WM, CSF andWMH. To guarantee
optimal correspondence of the maps with lesions as seen on the FLAIR image, WMH segmen-
tation maps were optimised by binarisation at a manually set threshold for each patient by a
blinded single rater. Manual refinement was performed where necessary to further improve
accuracy. Reliability metrics were calculated as per Dunn et al [24]. The inter-rater reliability
metrics were calculated using the mean values for each rater. WMH reliability metrics were
checked using a subset of 20 randomly selected subjects by two raters (EAZ and CL). All poten-
tially available time points were used for each subject in the reliability calculations. Both raters
were blinded with respect to the subject identity and time point of each scan, and the scan
order was randomized for each individual rater to avoid any potential bias. Intra-rater reliabil-
ity metrics were: Standard error of mean = 247mm3, mean variability = 7.78% (standard devia-
tion (SD) = 3.03%), Pearson’s intra-class correlation coefficient = 0.98. The inter-rater
reliability metrics were: Standard error of mean = 187mm3, mean variability = 5.57%
(SD = 3.99%), Pearson’s intraclass correlation coefficient = 0.99. Areas of lacunar damage were
manually identified on native space T1-weighted images with reference to the FLAIR images,
and segmented using a space-filling algorithm in ITK-SNAP (www.itksnap.org [25]). Grey
scale intensity thresholds for the space-filling algorithm were set between 350 and 500 with 500
iterations. Manual refinement was required to ensure accurate representation of lacunes of pre-
sumed vascular origin adjacent to the lateral ventricles using ITK-SNAP. Reliability metrics
were checked using a subset of 20 randomly selected scans by two raters (PB and CL), using the
same procedure as the WMH reliability metrics. The intra-rater reliability metrics were: Stan-
dard error of mean = 3mm3, mean variability = 7.93% (SD = 4.89%), Pearson’s intra-class cor-
relation coefficient = 0.99. The corresponding inter-rater reliability metrics were: Standard
error of mean = 2mm3, mean variability = 4.32% (SD = 4.19%), Pearson’s intraclass correlation
coefficient = 0.99.
The regions of lacunes of presumed vascular origin were removed from all tissue segmenta-
tion maps and classed as a fifth tissue class. All images were visually inspected to ensure consis-
tent segmentation quality. The similar intensity profile of GM andWMH on T1-weighted
images can cause tissue misclassification between GM andWM. To avoid this, the GM and
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WMmaps were corrected using the binarised WMH and lacune of presumed vascular origin
segmentations [20]. The NAWM tissue class was calculated by subtracting the WMH from the
corrected WMmap (Fig 2). GM, NAWM andWMH volumes were calculated in individual
space by summing the corrected segmented areas. Total brain volume was defined as the sum
of these three volumes.
2.3.2 Diffusion pre-processing. Diffusion-weighted images were pre-processed to remove
eddy current distortions using the FSL Linear Image Registration Tool (FLIRT, FMRIB Software
Library, www.fmrib.ox.ac.uk/fsl [26]). The positive and negative diffusion gradient direction
images were geometrically averaged to eliminate gradient cross-terms [27]. The 8 b = 0 images
were averaged to give a T2-weighted echo planar image, throughout referred to as b0 images.
Affine transformations, followed by non-linear transformations, were computed between intensity
inverted, skull stripped T1-weighted images and the skull stripped b0 image using FMRIB Non-
linear Image Registration Tool (FNIRT) [28]. The transformations were subsequently applied to
the native T1-weighted images, masks and all tissue segmentations to obtain tissue class images in
b0 space. The deformation quality was assessed for each individual using the warped T1-weighted
and b0 images. Masks included voxels with probabilities of GM, NAWMorWMH>0.5. Spurious
CSF voxels were removed from the tissue masks by application of a diffusivity threshold (i.e. vox-
els with MD>0.0026 mm2s-1 were considered to contain CSF and excluded).
2.3.3 DTI histogram analysis. Using DTIfit in FSL a diffusion tensor model was fitted for
each voxel from which tensor-derived FA, MD, RD and ADmaps were subsequently calculated
(Fig 3). Diffusion characteristics of NAWM, and NAWM plus WMH (All_WM) were
Fig 2. A. T1-weighted image B. FLAIR image C. Corresponding tissue segmentation map.
Abbreviations: GM = grey matter; NAWM = normal appearing white matter; Lac. = lacune of presumed
vascular origin; WMH = white matter hyperintensity.
doi:10.1371/journal.pone.0147836.g002
Fig 3. A. An axial fractional anisotropy and B. mean diffusivity map (mm2s-1). Images are from a 78 year
old male from the SCANS cohort and representative of DTI-derived maps of symptomatic cerebral small
vessel disease patients.
doi:10.1371/journal.pone.0147836.g003
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evaluated. Additionally, to quantify the stability of DTI parameters over time, MD histogram
measures were computed in CSF spaces. Normalised histograms of 1000 bins were produced
for FA, MD, RD and AD maps of the WM segmentations (FA range 0–1, bin width 0.001; MD,
AD and RD range 0–0.004, bin width 4×10−6). Since FA and diffusivity measures are non-nor-
mally distributed in WM, we evaluated longitudinal change of the following histogram param-
eters: median, peak value, peak height, skew and kurtosis. These parameters have also been
shown to have associations with cognition in a healthy older adult and SVD population
[6,29,30].
2.3.4 Missing MRI data. Out of the 99 patients included in the current study, for each of
the consecutive three year follow ups, scanning sessions were performed on 98, 77 and 71
patients, with DTI respectively available for 99, 96, 74 and 68 patients (Fig 1). Disproportionate
geometrical warping in diffusion-weighted images hindered accurate co-registration of four
cases at baseline and two at year 1. Reasons given for withdrawal from the study are provided
in Fig 1.
During follow-up three patients suffered new clinical strokes. Of these one patient had a
small cortical haemorrhage which was considered a study endpoint. The other two patients
had new small subcortical infarcts and were eligible to remain in the study according to the
protocol, one was however unable to do so due to disability and withdrew.
2.4 Statistical analysis
Differences between baseline demographics and neuroimaging characteristics of the 99 patients
included in the current study and those who did not attend any follow-up MRI were evaluated
using Mann-Whitney U and χ2 tests where appropriate in Statistical Package for Social Sci-
ences version 20.0 (SPSS, Chicago, IL, USA.).
Linear mixed-effects (LME) models in MLwiN (version 2.1, Centre for Multilevel Model-
ling, University of Bristol [31]) were used to assess the effects of time on the change in DTI
parameters in All_WM and NAWM tissue segmentations. The trajectories of the DTI parame-
ters for each individual were modelled as a linear trend across the follow-up period as a func-
tion of time (exact time since baseline assessment in years). Initial intercept and slope of each
patient’s linear trajectory were allowed to vary with both fixed and random effects. Fixed effect
variation was accounted for by time, and random effect variation allowed for remaining inter-
individual differences. The average fixed effect slope of time represents the average annualised
change rate for a parameter. The change rates of each DTI parameter were evaluated using a
Wald test. A Bonferroni corrected significance level of p0.0023 was used to correct for multi-
ple comparisons (i.e. 21 comparisons). Since sensitivity of progression markers depends on a
combination of significance and magnitude of change, as well as robustness of a model, resid-
ual errors were also calculated for all LME models. For comparison reasons, the change rates
and residual errors are also expressed as a percentage of the average intercept, which represent
the average baseline value.
Sample size estimations were carried out for all DTI parameters using longpower statistical
package in R version 3.02 (www.R-project.org) [32]. For these estimations all available data
was used and minimum sample sizes per treatment arm were calculated for a hypothetical
3-year trial with measurements taken at even yearly intervals. A balanced trial design was
assumed. A range of percentage treatment effects was calculated assuming 80% power with
α = 0.05.
DTI analysis produces many related parameters. To determine whether a more predictive
score could be developed by combining these different measures, we also performed principal
component analysis (PCA) using SPSS 20.0 to reduce the number of DTI parameters into one
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component that reflected the underlying variability in the data. PCA was applied to baseline
DTI values. Component scores for subsequent time points were calculated using the compo-
nent coefficients and standardised DTI values based on baseline values. To overcome the mul-
ticollinearity issue of highly correlated variables, we chose to exclude RD and AD parameters
from the PCA as they can be considered as subparameters of MD. When all candidate variables
were included in the PCA we observed problems with multicollinearity (correlation matrix
determinant<0.0001). When we restricted variables to those that declined significantly over
time in our primary analysis this problem was ameliorated. Principal components were
retained if eigenvalues were greater than 1. Promax rotation was applied. Following PCA, LME
models were also created for the principal component scores.
Results
3.1 Demographics
Study cohort demographics and the volumetric measures of the various tissue class segmenta-
tions are shown in Table 1. Patients not included in the longitudinal study cohort were signifi-
cantly older (p = 0.008), and had a lower score on the MMSE (p = 0.001). The mean age of the
analysed longitudinal study cohort was 68.9 (SD = 10.0) years at baseline, and 75.0 (SD = 6.8)
years for the patients in the non-longitudinal cohort. No differences were observed in baseline
brain volume and other neuroimaging characteristics between these cohorts.
3.2 DTI change over time
There was a highly significant change in most DTI parameters for both NAWM and All_WM
with p-values0.001 (Table 2). FA and diffusivity histogram metrics changed consistently
with a decrease in anisotropy and an increase in diffusivity, indicating a general increase in
Table 1. Baseline characteristics of the longitudinal study cohort.
Demographics and Longitudinal study Non-longitudinal study p-values
neuroimaging characteristics cohort cohort
N = 99 N = 22
Age (yrs) 68.9 ± 10.0 75.0 ± 6.8 0.008
Gender, % male 66.7 54.5 0.283
MMSE score 27.9 ± 2.4 25.7 ± 3.2 0.001
Rankin score 1.1 ± 1.0 1.7 ± 1.5 0.084
Hypertension (%) 92 (92.9) 20 (90.9) 0.744
Hypercholesterolaemia (%) 85 (85.9) 19 (86.4) 0.951
Diabetes mellitus (%) 19 (19.2) 5 (22.7) 0.599
Current smoker (%) 21 (21.2) 2 (9.1) 0.510
Brain Volume (ml) 1038.0 ± 104.1 1103.0 ± 121.3 0.065
WMH lesion load (%) 3.6 ± 2.5 4.2 ± 4.8 0.868
Lacunes of presumed vascular origin [range] 4.2 [0–27] 3.9 [0–14] 0.659
Numbers represent means ± standard deviation or percentages. Hypertension was deﬁned as systolic blood pressure >140 mmHg, diastolic >90 mmHg
or being on antihypertensive treatment. Hypercholesterolaemia was deﬁned as a serum total cholesterol >5.2 mmol/l or treatment with a statin.
Abbreviations: MMSE = Mini Mental State Examination; WMH lesion load = White matter hyperintensity volume as percentage of total brain volume. Bold
values differ signiﬁcantly between groups at a level of p <0.05.
doi:10.1371/journal.pone.0147836.t001
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WM ultrastructural damage over time. The percentage annualised change of different DTI
parameters ranged from 0.01% to 4.43% in All_WM tissue, and 0.15–5.96% in NAWM.
Table 2. DTI parameter progression values calculated through linear mixed effect models.
All_WM NAWM
Yearly rate of
change
%
annual
Residual
error
% residual
error
χ2 Yearly rate of
change (SD)
% annu al
change
Residual
error
%
residual
χ2
(SD) change error
Fractional Anisotropy
Median -2.17×10−3
(4.05×10−4)
-0.74 4.76×10−5 0.016 28.67 -2.82×10−3
(4.85×10−4)
-0.95 5.82×10−5 0.020 33.82
Peak height 3.27×10−7
(5.04×10−6)
0.01 1.00×10−8 <0.001 0.004 1.01×10−5
(5.10×10−6)
0.33 1.03×10−8 <0.001 4.647
Peak value -6.13×10−3
(1.65×10−3)
-2.25 6.08×10−4 0.223 13.86 -6.28×10−3
(1.68×10−3)
-2.26 7.15×10−4 0.257 13.99
Skew 0.010 (0.002) 1.46 1.17×10−3 0.171 22.65 0.016 (0.003) 2.34 1.33×10−3 0.195 35.19
Kurtosis 0.013 (0.006) 2.49 8.28×10−3 1.586 5.239 0.025 (0.007) 5.07 8.06×10−3 1.635 13.36
Mean Diffusivity
Median (mm2s-1) 5.36×10−6
(5.22×10−7)
0.67 7.86×10−11 <0.001 105.3 3.42×10−6
(4.66×10−7)
0.43 7.91×10−11 <0.001 53.94
Peak height -3.72×10−4
(3.12×10−5)
-2.44 2.68×10−7 0.002 141.7 -3.35×10−4
(3.57×10−5)
-2.05 3.63×10−7 0.002 87.94
Peak value
(mm2s-1)
2.85×10−6
(6.13×10−7)
0.37 1.11×10−10 <0.001 21.60 1.97×10−6
(5.79×10−7)
0.26 1.32×10−10 <0.001 11.64
Skew 0.017 (0.012) 0.68 0.053 2.120 2.592 0.029 (0.015) 0.99 0.083 2.833 3.966
Kurtosis -0.304 (0.129) 2.00 6.484 42.658 5.610 -0.091 (0.187) -0.45 13.84 68.440 0.237
Radial Diffusivity
Median (mm2s-1) 6.42×10−6
(1.25×10−6)
0.97 2.04×10−10 <0.001 26.53 4.92×10−6
(1.21×10−6)
0.75 2.02×10−10 <0.001 16.49
Peak height -2.70×10−4
(2.24×10−5)
-2.15 1.85×10−7 <0.001 144.6 -2.25×10−4
(2.48×10−5)
-1.69 2.41×10−7 0.002 81.85
Peak value
(mm2s-1)
4.34×10−6
(1.34×10−6)
0.68 3.10×10−10 <0.001 10.42 5.47×10−6
(1.37E-6)
0.86 3.05×10−10 <0.001 16.01
Skew 0.037 (0.010) 1.56 0.039 1.641 14.01 0.042 (0.012) 1.78 0.053 2.246 13.45
Kurtosis -0.114 (0.097) 0.95 3.676 30.633 1.399 0.023 (0.132) 0.16 6.943 48.299 0.031
Axial Diffusivity
Median (mm2s-1) 6.39×10−6
(5.96×10−7)
0.60 1.12×10−10 <0.001 114.8 3.01×10−6
(5.86×10−7)
0.29 1.23×10−10 <0.001 26.36
Peak height -1.24×10−4
(1.24×10−5)
1.47 4.59×10−8 <0.001 99.92 -6.18×10−5
(1.31×10−5)
0.68 6.51×10−8 <0.001 22.36
Peak value
(mm2s-1)
3.82×10−6
(1.15×10−6)
0.38 3.95×10−10 <0.001 11.01 1.46×10−6
(9.43×10−7)
0.15 3.52×10−10 <0.001 2.383
Skew 0.061 (0.007) 4.02 0.011 0.725 83.27 0.073 (0.008) 4.58 0.019 1.192 89.63
Kurtosis 0.230 (0.035) 4.43 0.494 9.515 42.45 0.379 (0.04) 5.96 0.778 12.235 73.19
Principal
component
score
0.129(0.016) 714 0.050 274 69.05 0.131(0.018) 431 0.059 194 55.24
Yearly rates of change are deﬁned as the mean estimates of the ﬁxed effects from the linear mixed effect models with their standard deviation (SD).
Percentages annual change and residual error are with respect to the average baseline value. Bold values have signiﬁcant annualised change rates at a
Bonferroni corrected level of p 0.0023.
doi:10.1371/journal.pone.0147836.t002
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There was a change in the shape of the FA histograms over time due to a reduction in FA
which manifested as decreased median and peak value, and an increased peak height (Fig 4A).
This reduction in FA values also created a greater positive skew (i.e. longer tail to the right,
All_WM: annualised change rate = 0.010, p<0.001; NAWM: annualised change rate = 0.016,
p<0.001) and an increased kurtosis (i.e. a stronger peaked distribution, NAWM: annualised
change rate = 0.025, p<0.001). Subtle differences over time were observed in the histogram
distributions of the three diffusivity measures, MD, RD and AD (Fig 4B–4D). Increased diffu-
sivity led to increased peak value and median, and decreased peak height values over time.
Changes in skew and kurtosis were not significant for MD, but for RD and AD there was an
increase in the skewness due to greater frequency of higher diffusivity voxels in the rightward
tail (All_WM: annualised change rate RD skew = 0.037, p<0.001; annualised change rate AD
skew = 0.061, p<0.001; NAWM: annualised change rate RD skew = 0.042, p<0.001; annual-
ised change rate AD skew = 0.073, p<0.001). An increase in kurtosis was also found for the
AD distribution representing a more peaked distribution (All_WM: annualised change
rate = 0.230, p<0.001; NAWM: annualised change rate = 0.778, p<0.001).
A significant change of most DTI parameters was also observed within regions of WMH (S1
Table). The direction of change was, however, opposite to that observed in NAWM and
All_WM. The estimated progression rates of FA metrics indicated increased anisotropy over
time. The FA histogram showed an increased median and peak value, and decreased peak
height (median FA: annualised change rate = 0.00332, p< 0.001; peak value FA: annualised
change rate = 0.00648, p = 0.002; peak height FA: annualised change rate = -0.000171,
Fig 4. Average DTI histogram distributions of the baseline longitudinal cohort and at 3 year follow-up. A. Fractional anisotropy. B. Mean diffusivity
(mm2s-1). C. Radial diffusivity (mm2s-1). D. Axial diffusivity (mm2s-1).
doi:10.1371/journal.pone.0147836.g004
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p< 0.001). Changes in histogram parameters of MD, RD and AD within WMH over time
indicated reduced diffusivity, as evidenced by decreased medians (MD: annualised change
rate = -8.20×10−6 mm2s-1, p< 0.001; RD: annualised change rate = -7.64×10−6 mm2s-1,
p< 0.001) and peak values (MD: annualised change rate = -1.46×10−5 mm2s-1, p< 0.001;
RD: annualised change rate = -1.06×10−5 mm2s-1, p< 0.001; AD: annualised change rate =
-1.08×10−5 mm2s-1, p = 0.002). Histogram peak height was reduced over time in all diffusivity
measures and skew increased.
Within the CSF the MDmedian, peak height, peak value and kurtosis remained stable over
time (see S2 Table). A significant change was found in MD skew in the CSF over time, such
that the skew became less negative, indicating that the MD distribution within the CSF became
more Gaussian over time (annualised change rate = 0.00267, p = 0.009).
Percentage residual error for each model was highly varied within both All_WM and
NAWM. In particular kurtosis of the diffusivity measures had high residual errors: 9.515–
42.658% within All_WM, and 12.235–68.440% within NAWM. Residual errors of skew models
in the diffusivity DTI parameters were also relatively high. For MD and RD, these errors were
larger than the annualised skew change rates.
The extracted principal component scores for All_WM and NAWM accounted respectively
for 80.6% and 74.9% of the variance in the PCA. Very large annualised change rates were
observed (annualised change All_WM: 714%; NAWM: 431%). Residual errors were equally
large but did not exceed annualised change rates.
3.3 Sample size estimations
Table 3 shows the results of the sample size estimations. Sample sizes required for treatment
trials varied greatly using the different DTI parameters. Assuming a treatment effect of 25%
the minimum sample sizes needed per treatment arm for DTI parameters of All_WM ranged
from 198 for MD peak height to 186043 for FA kurtosis, the range for NAWM being 356 for
MD peak height to 3059376 for MD skew. The principal component scores had smaller sample
size estimations than those of the majority of DTI parameters, with an estimation of 501 for
the All_WM component score and 679 within NAWM if a treatment effect of 25% was
observed. MD peak height however requires the smallest sample size.
Discussion
Our results demonstrate that DTI is sensitive to change in patients with SVD over a relatively
short duration of follow-up. Observed changes in DTI parameters were consistent with a pro-
gressive degradation of WM ultrastructure showing a decline in anisotropy and increase in dif-
fusivity in WM. However our analysis demonstrates that different DTI parameters show
marked differences in the sensitivity to change and errors. We have shown that the most sensi-
tive marker for SVD progression is MD peak height. This finding indicates greater stability of
MD values compared to its radial and axial counterparts, as well as sensitivity to change and a
good model fit. We also provide sample size estimates, which will be useful in planning clinical
trials using DTI as a surrogate marker. It follows that MD peak height has the smallest sample
size estimate.
Over three year follow-up most DTI histogram parameters changed significantly. Interpre-
tation of longitudinal DTI changes is not always straightforward. Changes in diffusivity histo-
gram distributions are due to increased tissue ultrastructural damage that manifests as
increases in diffusivity. This results in higher median and peak value, and a lower peak height
as higher diffusivity values are identified with greater frequency. Increases in diffusivity values
cause the rightward tail of the distribution to become broader, increasing the positive skew.
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Also, the related reduction of lower diffusivity values causes the diffusivity histograms to
become less peaked and have lower kurtosis. This negative change is observed in MD and RD
(All_WM), although it does not reach significance. For the remainder of kurtosis values, in RD
(NAWM) and AD, kurtosis increases, significantly in the case of the latter. This finding most
likely reflects the instability of AD as a reliable DTI measurement, indicated by the high resid-
ual errors in AD kurtosis models. Since AD is the diffusivity in the principal diffusion direction,
errors in eigenvalue sorting and inaccuracies in the approximation of the principal diffusion
direction using the DTI model will have a large impact on measurement of the AD parameter
[33]. High residual errors in AD models therefore indicate limited value of this parameter for
longitudinal assessment of SVD. MD, and to a lesser extent RD, may be more informative as
they are calculated from the average of two or more eigenvalues and appear to be more stable
measures.
Changes in the FA histogram distribution are due to reductions in FA that manifest as a
lower median and peak value, and a higher peak height due to identification of lower FA values
with greater frequency. In turn this causes a greater rightward tail of the distribution (greater
positive skew) and a more pronounced peak (greater kurtosis). However, FA histogram
Table 3. The minimum sample size estimation per arm required to test treatment effects of various percentages using DTI parameters.
All_WM NAWM
Minimum sample size (per arm) required to test
treatment effects of
Minimum sample size (per arm) required to test
treatment effects of
30% 25% 20% 15% 30% 25% 20% 15%
Fractional Anisotropy
Median 1215 1749 2733 4859 945 1361 2126 3780
Peak height 4391 6323 9880 17565 194040 279417 436590 776159
Peak value 4461 6424 10038 17845 4354 6270 9798 17418
Skew 1779 2562 4003 7117 900 1295 2024 3598
Kurtosis 129197 186043 290694 516788 4935 7106 11103 19739
Mean Diffusivity
Median 232 334 522 928 513 739 1154 2052
Peak height 138 198 310 551 248 356 557 990
Peak value 1869 2692 4205 7476 6193 8918 13935 24773
Skew 41083 59160 92437 164333 2124567 3059376 4780275 8498267
Kurtosis 66656 95982 149971 266615 7722 11120 17374 30888
Radial Diffusivity
Median 1493 2150 3360 5973 3350 4825 7538 13402
Peak height 141 204 318 566 267 384 601 1068
Peak value 8787 12653 19770 35147 3485 5018 7841 13940
Skew 6023 8673 13551 24091 5875 8461 13220 23502
Kurtosis 34160 49190 76859 136639 3652 5259 8217 15607
Axial Diffusivity
Median 183 264 412 733 1415 2038 3185 5662
Peak height 173 250 390 693 1799 2590 4047 7195
Peak value 7342 10572 16519 29368 88158 126948 198356 352632
Skew 268 386 604 1073 251 361 565 1004
Kurtosis 737 1062 1659 2950 337 485 758 1348
Principal component score 348 501 783 1392 472 679 1061 1887
doi:10.1371/journal.pone.0147836.t003
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parameters were found to have a poor longitudinal model fit with high residual error. This may
be due to ambiguity of FA values. In particular, as FA is defined by a quadratic function in
three related variables, similar FA values can represent different diffusion tensor (ellipsoidal)
shapes [34]. The dependency of FA on the three eigenvalues of the diffusion tensor leads to
reduced stability of FA compared to MD. The use of a component score combining MD and
FA measurements inevitably decreases sensitivity to detection of disease progression compared
to MDmeasurements alone. The observed sample size estimates of component scores also
reflect this effect.
Samples sizes depend on the detected power of observations. Power in turn relies on error,
so depends on measurement stability, effect size and in this case magnitude of change. Since
scanner upgrades can affect measurement of DTI histogram parameters [35], their effect was
evaluated. The results indicated that there was no significant change in MD histogram parame-
ters in CSF spaces, apart from for MD skew. In this case the results indicated that the MD dis-
tribution was becoming more Gaussian over time, representing an improvement in MD
quantification. These results assure validity of the observed rates of change in this study. The
finding of lowest sample size estimates for MD peak height and median therefore demonstrates
that the MD peak height benefits from being a highly stable measurement that is also sensitive
to change. Whether DTI parameters are calculated for All_WM or NAWM also impacts sam-
ple size. Histologically WMH tissue shows axonal loss and glial proliferation [36]. DTI studies
have shown that diffusivity is increased and anisotropy is lowered in WMHs compared to
NAWM in SVD and CADASIL, a young-onset genetic variant of SVD [4,37]. This contributes
to our finding of greater change in diffusivity parameters of All_WM tissue. Sample sizes esti-
mates of All_WM diffusivity parameters are therefore reduced compared to parameter estima-
tion in NAWM. For FA parameters, however, greatest change and lowest samples size
estimates were obtained for FA measures from NAWM tissue compared with FA measures
from All_WM. The severity of damage found in WMHs affects the uncertainty of the orienta-
tion of the principal diffusivities from which FA is calculated and will likely provide inconsis-
tencies in FA [34]. This leads to greater sample size estimates for FA parameters within
All_WM. Changes to diffusion characteristics of WMHs over time revealed the opposite effect
to those observed in in NAWM and All_WM. The increase in anisotropy and decrease in diffu-
sivity over time suggests improvement of tissue microstructure within WMHs; however, this is
unlikely to be the case. Maillard et al., [38] have shown that voxels containing higher FA and
lower diffusivity values are located at the edges of WMHs, indicating that the core of WMHs
has greater microstructural damage than newly formed areas of WMH. Our observation of an
apparent tissue microstructural improvement is likely to be the consequence of WMH growth
(and changes in the surface area to volume ratio of the WMHs) and provides a misleading indi-
cation of improvement. Consequently, WMH diffusion characteristics provide an ambiguous
and unsuitable marker for monitoring disease progression.
Despite relatively high patient dropout rates which could bias the sample to those with less
decline, significant changes were detected in our cohort. The patient group who did not attend
follow-up were older and had worse cognitive levels, indicating that such patients may be more
vulnerable to decline and consequently an underestimation of actual change in DTI parameters
in the study population. Secondly, the use of small histogram bin-widths in our analyses
increased noise in measurements of peak value and peak height. A trade-off between sensitivity
and noise is applicable when deciding on histogram bin size. We have however shown that
annualized change rates of DTI parameter peak value and peak height are small and therefore
require small histogram bin widths to enable detection of change. Also, we have generated his-
tograms fromWM tissue because SVD predominantly affects the subcortical structures, and in
pilot studies we have shown that DTI parameters were sensitive to change in WM over short
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time periods in SVD [29]. However, it is now recognised that SVD does cause cortical GM
pathology as well, with both atrophy and micro infarcts, and it is possible that a global whole
brain DTI measure may be a simpler alternative. Finally, the absence of an age-matched control
population is a limitation to this study, as observed changes in diffusion characteristics could
be a result of SVD associated pathology and ageing. The ageing literature shows varying change
rates of diffusion parameter. Most studies reveal smaller rates of change than found in our
cohort. Nusbaum et al., [39] for example found age-related histogram changes in ADC, a diffu-
sion weighted imaging equivalent to MD in SVD [35], that were approximately 8 times smaller
than our MD changes. More recently, longitudinal FA and diffusivity changes in ageing have
been shown to have annual percentage changes 2–3 times smaller than those in our cohort
[40]. Lastly, a study directly comparing DTI parameters of CADASIL patients to age-matched
controls revealed no change in MD peak value in the ageing population and an annual progres-
sion of 3.65×10−6 mm2s-1 in CADASIL [41] which is slightly greater than the 2.85 over time
indicated reduced diffusivity, as evidenced by decreased medians 10−6 mm2s-1 change found in
this study. Charlton et al., [30] on the other hand, reported slightly larger FA and MD changes
in their elderly population. This discrepancy could be the result of quantifying change as the
difference between two time points. Measurement noise and missing data will have a greater
effect on change rates the fewer follow-up time points are acquired. Previously we have shown
that analysis of fewer data points leads to greater magnitudes of change, as shown by smaller
sample size estimates of hypothetical clinical trials [42]. Together these findings assure us that
the progression rates as measured in our cohort represent SVD progression beyond pure age-
related WM changes.
Our data suggests disease progression in SVD can be monitored sensitively using DTI histo-
gram analysis. This is in line with earlier whole brain DTI histogram in ageing [30], sporadic
SVD [29] and CADASIL [41], that have provided highly reproducible DTI markers suitable for
longitudinal studies [43,44]. Since changes in cognition over the same duration in the same
cohort have been small and significant for only one cognitive domain or even absent, depend-
ing on the statistical analysis applied [2,42], we suggest DTI could be attractive as a surrogate
marker to follow disease progression and test the effect of therapeutic interventions in SVD.
Other imaging parameters that are thought to be potential surrogate markers are brain atro-
phy, WMH growth and incident lacunes. Previously we have shown in the same cohort that
development of new lacunes only occurred in a minority of SVD patients, there was however
significant atrophy and WMH growth over a period of 3 years [42]. Additionally, in [42] we
investigated progression of one DTI parameter, MD peak height of All_WM. Sample size esti-
mates showed that WMH volume and MD peak height were most sensitive to change and
most suitable as surrogate marker of disease progression. The current study provides evidence
that MD peak height of All_WM is the most sensitive DTI parameter for use in longitudinal
SVD studies.
Apart from being able to detect prospective change MRI markers will have to meet further
requirements to fulfil all criteria of a validated surrogate marker [45]; one of the most impor-
tant being, being able to predict future clinical cognitive decline. Such associations have been
weak and inconsistent with regards to WMH volume [29,41,46]. Previous cross-sectional stud-
ies have on the other hand shown that DTI histogram parameters correlate strongly with cog-
nition in SVD populations [6,8,29]. Analyses of longitudinal correlations between cognitive
and DTI change, and investigating the interventional effect on DTI markers and cognition
therefore now clearly represent the next phase for determining the potential of DTI as a future
surrogate marker of SVD. The present study is continuing cognitive follow-up to 5 years, and
plans to correlate cognitive changes over this period with MRI parameters if significant cogni-
tive change is detectable over this longer period.
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In summary, we observed significant longitudinal change in various DTI histogram parame-
ters in WM in a SVD cohort of patients with symptomatic lacunar stroke and confluent areas
of WMH of presumed vascular origin. The reliability and sensitivity of individual DTI histo-
gram parameters as markers of disease progression is however highly variable. Our results sug-
gest MD peak height is the most sensitive marker for detecting ultrastructural brain tissue
damage in SVD. Future studies investigating progression of SVD and the use of DTI as a surro-
gate disease marker are needed and should focus on the relationship between the clinical out-
comes of SVD and imaging markers.
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